Differential effects of MDMA and methylphenidate on social cognition

Abstract

Social cognition is important in everyday-life social interactions. The social cognitive effects of 3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’) and methylphenidate (both used for neuroenhancement and as party drugs) are largely unknown. We investigated the acute effects of MDMA (75 mg), methylphenidate (40 mg) and placebo using the Facial Emotion Recognition Task, Multifaceted Empathy Test, Movie for the Assessment of Social Cognition, Social Value Orientation Test and the Moral Judgment Task in a cross-over study in 30 healthy subjects. Additionally, subjective, autonomic, pharmacokinetic, endocrine and adverse drug effects were measured. MDMA enhanced emotional empathy for positive emotionally charged situations in the MET and tended to reduce the recognition of sad faces in the Facial Emotion Recognition Task. MDMA had no effects on cognitive empathy in the Multifaceted Empathy Test or social cognitive inferences in the Movie for the Assessment of Social Cognition. MDMA produced subjective ‘empathogenic’ effects, such as drug liking, closeness to others, openness and trust. In contrast, methylphenidate lacked such subjective effects and did not alter emotional processing, empathy or mental perspective-taking. MDMA but not methylphenidate increased the plasma levels of oxytocin and prolactin. None of the drugs influenced moral judgment. Effects on emotion recognition and emotional empathy were evident at a low dose of MDMA and likely contribute to the popularity of the drug.

Keywords

MDMA ecstasy methylphenidate empathy emotion recognition social cognition

Get full access to this article

View all access options for this article.

References

Bedi

Hyman

de Wit

(2010) Is ecstasy an ‘empathogen’? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others. Biol Psychiatry 68: 1134–1140.

Brunt

Koeter

Niesink

. (2012) Linking the pharmacological content of ecstasy tablets to the subjective experiences of drug users. Psychopharmacology 220: 751–762.

Crockett

(2009) The neurochemistry of fairness: Clarifying the link between serotonin and prosocial behavior. Ann N Y Acad Sci 1167: 76–86.

Crockett

Clark

Hauser

. (2010) Serotonin selectively influences moral judgment and behavior through effects on harm aversion. Proc Natl Acad Sci U S A 107: 17433–17438.

Di Simplicio

Massey-Chase

Cowen

. (2009) Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers. J Psychopharmacol 23: 241–248.

Dumont

Sweep

van der Steen

. (2009) Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration. Soc Neurosci 4: 359–366.

Dunand

Gubian

Stauffer

. (2013) High throughput and sensitive quantitation of plasma catecholamines by ultraperformance liquid chromatography-tandem mass spectrometry using a solid phase microwell extraction plate. Anal Chem 85: 3539–3544.

Dziobek

Fleck

Kalbe

. (2006) Introducing MASC: A movie for the assessment of social cognition. J Autism Dev Disord 36: 623–636.

Dziobek

Rogers

Fleck

. (2008) Dissociation of cognitive and emotional empathy in adults with Asperger syndrome using the Multifaceted Empathy Test (MET). J Autism Dev Disord 38: 464–473.

10.

EMCDDA (2014) European Monitoring Center for Drugs and Drug Addiction (EMCDDA). Available at: www.emcdda.europa.eu/publications/mdma/publications/mdma (accessed 26 June 2014).

11.

Harmer

Shelley

Cowen

. (2004) Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am J Psychiatry 161: 1256–1263.

12.

Hurlemann

Patin

Onur

. (2010) Oxytocin enhances amygdala-dependent, socially reinforced learning and emotional empathy in humans. J Neurosci 30: 4999–5007.

13.

Hysek

Liechti

(2012) Effects of MDMA alone and after pretreatement with reboxetine, duloxetine, clonidine, carvedilol, and doxazosin on pupillary light reflex. Psychopharmacology 224: 363–376.

14.

Hysek

Domes

Liechti

(2012a) MDMA enhances ‘mind reading’ of positive emotions and impairs ‘mind reading’ of negative emotions. Psychopharmacology 222: 293–302.

15.

Hysek

Schmid

Simmler

. (2013) MDMA enhances emotional empathy and prosocial behavior. Soc Cogn Affect Neurosci. DOI: 10.1093/scan/nst/161, (Epub ahead of print 28 October 2013).

16.

Hysek

Simmler

Ineichen

. (2011) The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA (‘ecstasy’) in humans. Clin Pharmacol Ther 90: 246–255.

17.

Hysek

Simmler

Nicola

. (2012b) Duloxetine inhibits effects of MDMA (‘ecstasy’) in vitro and in humans in a randomized placebo-controlled laboratory study. PLoS One 7: e36476.

18.

Hysek

Simmler

Schillinger

. (2014) Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone and in combination. Int J Neuropsychopharmacol 17: 371–381.

19.

Janke

Debus

(1978) Die Eigenschaftswörterliste. Göttingen: Hogrefe.

20.

Kamboj

Joye

Bisby

. (2013) Processing of facial affect in social drinkers: A dose–response study of alcohol using dynamic emotion expressions. Psychopharmacology 227: 31–39.

21.

Kometer

Schmidt

Bachmann

. (2012) Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors. Biol Psychiatry 72: 898–906.

22.

McCabe

Knight

Teter

. (2005) Non-medical use of prescription stimulants among US college students: Prevalence and correlates from a national survey. Addiction 100: 96–106.

23.

Maoz

Tsviban

Gvirts

. (2014) Stimulants improve theory of mind in children with attention deficit/hyperactivity disorder. J Psychopharmacol 28: 212–219.

24.

Mitchell

Beck

Boyal

. (2011) Theory of mind deficits following acute alcohol intoxication. Eur Addict Res 17: 164–168.

25.

Mithoefer

Wagner

Mithoefer

. (2010) The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. J Psychopharmacol 25: 439–452.

26.

Moore

Clark

Kane

(2008) Who shalt not kill? Individual differences in working memory capacity, executive control, and moral judgment. Psychol Sci 19: 549–557.

27.

Morgan

Noronha

Muetzelfeldt

. (2013) Harms and benefits associated with psychoactive drugs: Findings of an international survey of active drug users. J Psychopharmacol 27: 497–506.

28.

Murphy

Ackermann

Handgraaf

MJJ

(2011) Measuring social value orientation. Judg Decis Making 6: 771–781.

29.

Neumann

Maloumby

Beiderbeck

. (2013) Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice. Psychoneuroendocrinology 38: 1985–1993.

30.

Oehen

Traber

Widmer

. (2013) A randomized, controlled pilot study of MDMA ±3,4-methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD). J Psychopharmacol 27: 40–52.

31.

Preller

Hulka

Vonmoos

. (2014) Impaired emotional empathy and related social network deficits in cocaine users. Addict Biol 19: 452–66.

32.

Ramos

Hicks

Kevin

. (2013) Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3,4-methylenedioxymethamphetamine in rats: Involvement of the V_1A receptor. Neuropsychopharmacology 38: 2249–2259.

33.

Schmeichel

Berridge

(2013) Neurocircuitry underlying the preferential sensitivity of prefrontal catecholamines to low-dose psychostimulants. Neuropsychopharmacology 38: 1079–1084.

34.

Simmler

Hysek

Liechti

(2011) Sex differences in the effects of MDMA (ecstasy) on plasma copeptin in healthy subjects. J Clin Endocrinol Metab 96: 2844–2850.

35.

Studerus

Gamma

Vollenweider

(2010) Psychometric evaluation of the altered states of consciousness rating scale (OAV). PLoS One 5: e12412.

36.

Thompson

Callaghan

Hunt

. (2007) A role for oxytocin and 5-HT_1A receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine (‘ecstasy’). Neuroscience 146: 509–514.

37.

Wardle

Garner

Munafo

. (2012) Amphetamine as a social drug: Effects of d-amphetamine on social processing and behavior. Psychopharmacology 223: 199–210.

38.

White

Justice

de Wit

(2002) Differential subjective effects of D-amphetamine by gender, hormone levels and menstrual cycle phase. Pharmacol Biochem Behav 73: 729–741.

39.

Williams

Hermens

Palmer

. (2008) Misinterpreting emotional expressions in attention-deficit/hyperactivity disorder: Evidence for a neural marker and stimulant effects. Biol Psychiatry 63: 917–926.

40.

Zerssen

(1976) Die Beschwerden-Liste. Münchener Informationssystem. Munich: Psychis.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

1.07 MB